Pulmotect, Inc.
  • Home
  • About Us
    • Our Company
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Our Approach
    • Overview
    • Our Science
    • Our Pipeline
    • Published Journal Articles
  • News
  • Contact Us

Houston company testing drug to protect against COVID 19

Posted on May 8, 2020May 8, 2020 by Brenton Scott
Posted in News Coverage

Post navigation

Pulmotect receives FDA approval to commence two Phase-2 trials targeting COVID-19
Houston biotech company gets green light from FDA to test coronavirus-fighting drug
Pulmotect Inc

3900 Essex Ln, Suite 575
Houston, TX 77027
Contact Us

© 2025
Pulmotect, Inc.